|
FY2025
12 months to Aug 31, 2025
|
FY2024
12 months to Aug 31, 2024
|
FY2023
12 months to Aug 31, 2023
|
FY2022
12 months to Aug 31, 2022
|
FY2021
12 months to Aug 31, 2021
|
|
|---|---|---|---|---|---|
| Net Income (Loss) | |||||
| Depreciation | |||||
| Share based payment | |||||
| Interest on Convertible loan | |||||
| Capital loss (Gain) | |||||
| Accounts Receivable and prepaid expenses | |||||
| Accounts payable and accrued liabilities | |||||
| Net cash used in operating activities | |||||
| Sale of equipment | |||||
| Realization of Held for trading investments | |||||
| Acquisition of equipment | |||||
| Net cash used in investing activities | |||||
| Proceeds from issuance of a Convertible loan | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash | |||||
| Effect of exchange rate fluctuations on cash | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of the year | |||||
| Significant non-cash transactions: | |||||
| Exercise of a Convertible loan to shares of common stock. | |||||
Loading...